Product Information
NUVESSA VAGINAL 1.3% GEL is a brand product labeled by Exeltis USA, Inc., priced at $42.9975 per GM under NDC 00642746605. Its NADAC has been published 366 times since Aug 21, 2019.
FDA first approved this application on Mar 24, 2014.
The High Outlier badge above means this manufacturer's average price in the metronidazole market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
65 mg/5g
Manufacturer
Exeltis USA, Inc.NDC
00642746605
Classification
Brand
Dosage Form
GEL
Route
TOPICAL
Effective Date
8/19/2026
Active Ingredients
METRONIDAZOLEApproval Type
New Drug (NDA)
FDA Application
NDA205223FDA Approved
3/24/2014
On Market Since
3/10/2018
Pharmacological Classes
Price Statistics
The NADAC for NUVESSA VAGINAL 1.3% GEL has been published 366 times since Aug 21, 2019, and over the history we have for it it has risen 22.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $42.9975 per GM |
|---|---|
| All-time high | $43.0916 (May 13, 2026) |
| All-time low | $35.1575 (May 27, 2020) |
| 52-week high | $43.0916 |
| 52-week low | $41.0364 |
| Median price | $37.2009 |
| Average price | $37.6606 |
| Largest weekly change | +5.0% (Jan 10, 2024) |
| Weeks tracked | 366 |
| Tracking since | Aug 21, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the metronidazole market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of NUVESSA VAGINAL 1.3% GEL?
The current National Average Drug Acquisition Cost (NADAC) for NUVESSA VAGINAL 1.3% GEL, manufactured by Exeltis USA, Inc., is $42.9975 per GM (NDC 00642746605), effective Aug 19, 2026.
How has the price of NUVESSA VAGINAL 1.3% GEL changed over time?
Over the history we have for it, the NADAC for NUVESSA VAGINAL 1.3% GEL has risen 22.3%. It has been tracked across 366 weekly CMS publications since Aug 21, 2019.
What are the highest and lowest recorded NADAC prices for NUVESSA VAGINAL 1.3% GEL?
Since Aug 21, 2019, the NADAC for NUVESSA VAGINAL 1.3% GEL has ranged from a low of $35.1575 (May 27, 2020) to a high of $43.0916 (May 13, 2026), with a median of $37.2009 per GM.
Are there cheaper alternatives to NUVESSA VAGINAL 1.3% GEL?
No other NADAC-published product currently shares the active ingredient and strength of NUVESSA VAGINAL 1.3% GEL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures NUVESSA VAGINAL 1.3% GEL?
NUVESSA VAGINAL 1.3% GEL (NDC 00642746605) is labeled by Exeltis USA, Inc., and CMS classifies it as a brand product.